Toronto hospital abruptly shutters mental health program for Chinese-Canadians
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
13 minutes ago
- Globe and Mail
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams. WARREN, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN) today announced that its artificial intelligence initiative, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to build the beta version of its foundational PredicTcell model. Powered by the Databricks Data Intelligence Platform and backed by their innovative engineering teams, has begun curating a dataset focused on oncology. The dataset, aggregated with the initial virology dataset. aims to improve upon the accuracy of the alpha version of PredicTcell model. This next phase of development builds on recently published international patent application (WO 2025/129197), which outlines novel machine learning systems for predicting immunologically active peptides, a critical step in developing targeted therapies for cancers and infectious diseases. 'We have been extremely fortunate to work with such great organizations like Microsoft and Databricks to build the alpha version of our foundational AI model,' said Mittul Mehta, Chief Information Officer and Head of 'Oncology represents one of the most impactful areas for AI in drug discovery, given the complexity of the disease and the limited availability of high-quality datasets.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law.
CTV News
26 minutes ago
- CTV News
Ontario invests $4.1M to expand access to primary care in Waterloo Region
The Ontario government is investing $4.1 million this year to help connect more residents in Waterloo Region to a family doctor or primary care provider. The funding is part of Ontario's $2.1 billion Primary Care Action Plan, which aims to connect 300,000 people across the province to publicly funded primary care services. Local health teams receiving funding include Community Healthcaring Kitchener-Waterloo, New Vision Family Health Team, Waterloo Region Nurse Practitioner-Led Clinic and Woolwich Community Health Centre. '[It will] connect thousands of residents across Waterloo Region to the care they deserve,' said Mike Harris, MPP for Kitchener-Conestoga, in a media release. 'I'm proud to see our region leading the way in building a more connected and accessible health-care system.' announcement MPP for Kitchener-Conestoga Mike Harris and MPP for Kitchener South-Hespeler Jess Dixon at Community Healthcaring Kitchener-Waterloo. (Hannah Schmidt/CTV Kitchener) Each team was selected through a proposal process that prioritized communities with high numbers of residents lacking access to primary care — including those currently on the Health Care Connect waitlist. According to the province, the selected teams have committed to attaching a 'high proportion' of unattached residents in their designated postal codes within the next year. 'We have not been able to intake as many patients as we should be,' said Tara Groves-Taylor, CEO of Community Healthcaring Kitchener-Waterloo. 'We sit at about 130 per cent of our capacity at our current numbers. We serve over 26, 000 patients. I think we're in an incredible position to lead a lot of this work, whether it be through the primary care, through the Heart Hubs or any other funding that we are benefiting from here in Kitchener-Waterloo. We are leaders.' The province says these investments will expand the work of local teams already serving vulnerable populations and support efforts to reduce wait times and gaps in access. The investment is part of more than $235 million allocated in 2025–26 for over 130 new and expanded primary care teams province-wide.
Globe and Mail
33 minutes ago
- Globe and Mail
Parts of northern Ontario under air quality statement as smoke from wildfires persists
A stretch of northern Ontario remains under a special air quality statement today amid smoke from wildfires burning in parts of the country. The special statement for southern parts of the province, including the Toronto area, lifted this morning as conditions there improved. Environment Canada says smoke from forest fires can cause reduced air quality and visibility that can fluctuate throughout the day. It says northern parts of the province, including Pikangikum and Sandy Lake First Nations, are under air quality statements or warnings due to the smoke. The weather agency says reduced air quality can cause mild eye, nose and throat irritation. More serious but less common symptoms include chest pains and a severe cough. Environment Canada is advising people to limit their time outdoors and consider postponing sports or other outdoor activities.
